Company: CMND
Filing Date: 2025-09-15
Form Type: POS AM
Source: 0001213900-25-087398
Chunk: 48

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-15
Form: POS AM
Chunk 48
---
 described in Item 6 hereof, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification              
 is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification           
 against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling      
 person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling 
 person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has        
 been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by          
 it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.                          |

| (d) | The undersigned registrant hereby undertakes that: |

| (1) | That for purposes of determining any liability under                                                                             
 the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance 
 upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4), or 497(h)        
 under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.     |

| (2) | That for the purpose of determining any liability under                                                                          
 the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration    
 statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the 
 initial bona fide offering thereof.                                                                                              |

<div align='center'>II-5

EXHIBIT INDEX</div>

| EXHIBIT 
 NUMBER  |     | EXHIBIT                                                                                                                               
 DESCRIPTION                                                                                                                           |
| 3.1     |     | Articles                                                                                                                              
 of Association of the Registrant, as currently in effect (incorporated herein by reference to Exhibit 3.1 to the registrant’s         
 registration statement on Form F-1, as amended, filed with the SEC on August 18, 2022 (File No. 333-265900))                          |
| 5.1*    |     | Opinion                                                                                                                               
 of Daniel Bloch, Canadian counsel to the Registrant